Clin2
NCT05109936Possibly a fitRecruiting

Febuxostat given right away versus later for gout flare

Gout

Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.

This Phase 3 study compares starting febuxostat immediately during a gout flare versus delaying the start. It aims to see which timing helps control gout better and safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
128 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older
  • Your gout flare must be new or diagnosed within the last 5 days
  • The flare must be in a peripheral joint (like a toe, foot, ankle, knee, or hand)
  • Your blood uric acid level must be high enough (uricemia ≥ 420 micromol/L), even if you take a “water pill” (diuretic)
  • Your kidneys must work enough (creatinine clearance at least 30 mL/min)
  • You must be able to read, understand the study info, and sign consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07414394Recruiting· Phase 3
Tigulixostat vs febuxostat for gout patients

This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.

Shanghai, Shanghai Municipality
NCT06622603Recruiting· Phase 4
Testing lower doses of febuxostat in well-controlled gout

This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.

Seongnam-si, Gyeonggi-do
NCT06995339Recruiting· Phase 2
Metformin vs. Febuxostat for gout in obesity without diabetes

This study compares two medicines—metformin (usually for diabetes) and febuxostat (for gout)—in people who have both gout and obesity but not diabetes. The goal is to see which works better for controlling gout and related health markers.

Damietta, New Damietta
NCT04875702Recruiting· Phase 4
Compare urate targets to reduce gout attacks or symptoms

This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.

South Birmingham, Alabama
NCT07661030Not yet recruiting· Phase 4
Timing of dotinurad for gout flare relief

This trial tests whether starting dotinurad, a medication that lowers uric acid, at different times after a gout flare begins can help the flare resolve faster. It may help people with frequent or severe gout attacks find quicker relief.

NCT06887452Not yet recruiting
Pharmacist-led gout treatment for veterans

This study tests whether a pharmacist-led program can help veterans with gout better manage their uric acid levels using common medications like allopurinol or febuxostat. If you have had a gout flare in the last 6 months and are already taking or starting a urate-lowering medication, this trial may be for you.

Omaha, Nebraska

Hear when a new Gout trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.